Defective granulocyte regulation in the Chediak-Higashi syndrome.
D000293:Adolescent; D000328:Adult; D000380:Agranulocytosis / Q000150:complications; D000417:Albinism / Q000150:complications*; D000743:Anemia, Hemolytic / Q000150:complications; D001772:Blood Cell Count; D001773:Blood Cells / Q000201:enzymology; D001792:Blood Platelets; D001854:Bone Marrow Cells; D002648:Child; D005043:Etiocholanolone / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000097:blood / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D006801:Humans; D006971:Hypersplenism / Q000150:complications / Q000188:drug therapy; D007700:Kinetics; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D008027:Light; D008214:Lymphocytes; D008297:Male; D009000:Monocytes; D009113:Muramidase / Q000097:blood / Q000652:urine; D011241:Prednisone / Q000627:therapeutic use; D013163:Splenomegaly / Q000150:complications; D013921:Thrombocytopenia / Q000150:complications
D005043:Etiocholanolone; D009113:Muramidase; D011241:Prednisone